| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.017 |
0.9 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |